BIRC5: A novel therapeutic target for lung cancer stem cells and glioma stem cells.

Kahm, Yeon-Jee; Kim, Rae-Kwon

Kahm, Yeon-Jee; Kim, Rae-Kwon.

Kahm YJ; Department of Environmental Safety Technology Research, Korea Atomic Energy Research Institute, Yuseong-Gu, Daejeon, 34057, Republic of Korea; Department of Radiation Life Science, Korea University of Science and Technology, Yuseong-Gu, Daejeon, 34113, Republic of Korea.
Kim RK; Department of Environmental Safety Technology Research, Korea Atomic Energy Research Institute, Yuseong-Gu, Daejeon, 34057, Republic of Korea; Department of Radiation Life Science, Korea University of Science and Technology, Yuseong-Gu, Daejeon, 34113, Republic of Korea. Electronic address: rkim@kaeri.re.kr.

Biochem Biophys Res Commun ; 682: 141-147, 2023 11 19.

Article en En | MEDLINE | ID: mdl-37806253

Asunto(s)

Neoplasias Pulmonares; Inhibidor 1 de Activador Plasminogénico; Humanos; Transición Epitelial-Mesenquimal; Neoplasias Pulmonares/genética; Células Madre Neoplásicas; Pulmón; Survivin/genética

Palabras clave

Baculoviral inhibitor of apoptosis repeat containing 5; Cancer stem cells; Epithelial to mesenchymal transition; Plasminogen activator inhibitor-1; Survivin

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidor 1 de Activador Plasminogénico / Neoplasias Pulmonares Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google